Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casesneurology-neurodisability-and-neuromuscular

Paeds Cases · neurology-neurodisability-and-neuromuscular

Status epilepticus: Case

Clinical case of a child presenting in established convulsive status epilepticus, covering the stepwise pathway from benzodiazepine to second-line levetiracetam, the reversible-cause search, the trial evidence for the second-line choice, the escalation to refractory management with rapid sequence intubation and continuous EEG, and the family counselling and follow-up.

paediatric emergency long case
On this page & tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 5-year-old boy is brought to the emergency department after a generalized tonic-clonic seizure that began twenty-five minutes ago and has not stopped. He has no prior history of epilepsy. His temperature is 39.0 degrees Celsius, his capillary glucose is 5.1 millimoles per litre, and his weight is 19 kilograms. He has received two doses of intravenous lorazepam with no effect.

This boy is in established convulsive status epilepticus bordering on refractory. The seizure has lasted twenty-five minutes, which places him just short of the ILAE t2 of thirty minutes, and he has already received two benzodiazepine doses without effect. His glucose is normal, so hypoglycaemia is excluded, and his fever and his first-presentation status raise a central nervous system infection as the likely trigger. The priority is to give a second-line agent at once and to prepare for refractory escalation. [1]

Clinical findings and assessment

The key findings are the continuous convulsion at twenty-five minutes, the failure of two adequate benzodiazepine doses, the fever of 39.0 degrees, and the normal glucose. The boy has crossed the t1 threshold of five minutes and is approaching the t2 threshold of thirty minutes, which places him in the established phase bordering on refractory. Because two benzodiazepine doses have failed, the next step is a second-line agent, not a third benzodiazepine, since the GABA-A receptors have internalised and further benzodiazepine doses add respiratory depression without adding efficacy. [2]

The differential of a first febrile presentation in status includes a central nervous system infection such as meningitis or encephalitis, a complex febrile seizure that has evolved into febrile status, and a first presentation of epilepsy provoked by fever. The absence of a prior seizure history and the high fever make an infectious cause the working diagnosis, which directs the investigation toward the blood culture, the lumbar puncture once stable, and the empirical antibiotics and aciclovir. [5]

Immediate management

The immediate management is to give a second-line agent now. My preferred agent is levetiracetam at 40 mg per kg intravenously, which is 760 mg for a 19 kg child, to a maximum of 4.5 g, infused over five minutes. The alternative is fosphenytoin at 20 mg phenytoin-equivalent per kg, which is 380 mg phenytoin-equivalent, to a maximum of 1500 mg phenytoin-equivalent, over ten minutes with cardiac monitoring. I would choose levetiracetam because the ConSEPT and EcLiPSE trials showed it is at least as effective as phenytoin in children with a better safety profile, and ESETT confirmed that levetiracetam, fosphenytoin, and valproate are equally effective across the age range. [3][4]

If the seizure does not stop with the second-line agent, the boy will have refractory status epilepticus, and I would escalate to rapid sequence intubation to protect the airway and ventilate, followed by a continuous midazolam, propofol, or thiopentone infusion titrated to burst suppression on the EEG. Continuous EEG monitoring would be mandatory from the moment of intubation, because the boy would be paralysed and the cortical seizure could continue unseen, and the only way to know whether the treatment is working is the EEG. [2]

Cause search and intensive care

The reversible causes are sought and treated in parallel with the drugs. The fever and the first-presentation status make a central nervous system infection the priority, so I would send a full blood count, a blood culture, electrolytes including calcium and magnesium, a venous gas, and a C-reactive protein. Once the seizure is controlled and the coagulation and platelets are checked, I would perform a lumbar puncture and start empirical antibiotics and aciclovir without delay. A computed tomography would be performed once the boy is stable, and a magnetic resonance imaging later to seek a structural cause if the workup is otherwise negative. [5]

The boy would be admitted to the paediatric intensive care unit, because he has required a second-line agent and is at high risk of refractory progression and of non-convulsive status once the convulsion is controlled. The intensive care team would manage the airway, the ventilation, and the anaesthetic infusion, with continuous EEG to confirm that the brain is electrically controlled. The paediatric neurology and infectious disease teams would be involved early to guide the cause search and the longer-term plan. [5]

Outcome and follow-up

The prognosis of a first febrile presentation in status depends on the underlying cause and on the duration of the seizure before control. The fever and the infectious cause are reassuring in the sense that they are treatable, and the boy has a good chance of full recovery if the seizure is controlled promptly and the infection is treated. The risk of subsequent epilepsy is elevated after a first presentation in status, and the risk of recurrence of status is about one in six, which is why the boy would be followed up in a paediatric neurology clinic. [5]

I would counsel the family honestly at every stage. I would explain that their son has been in a prolonged seizure that did not stop on its own, that the medicines are being given in a stepwise order to stop it, and that the blood tests and the lumbar puncture are looking for an infection that can be treated. I would explain that if the seizure does not stop with the second drug he will need a breathing machine and intensive care, that his brain will be watched with an EEG throughout, and that the team will return to explain the findings and the plan as soon as the seizure is controlled. Before discharge, the family would be connected to the paediatric neurology service, and a rescue plan would be discussed for any future episode. [5]

References

  1. [1]Trinka E, Cock H, Hesdorffer D, et al A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus Epilepsia, 2015.PMID 26336950
  2. [2]Glauser T, Shinnar S, Gloss D, et al Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society Epilepsy Curr, 2016.PMID 26900382
  3. [3]Kapur J, Elm J, Chamberlain JM, et al Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus N Engl J Med, 2019.PMID 31774955
  4. [4]Dalziel SR, Borland ML, Furyk J, et al Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial Lancet, 2019.PMID 31005386
  5. [5]Abend NS, Loddenkemper T Pediatric status epilepticus management Curr Opin Pediatr, 2014.PMID 25304961